Pyxis Oncology, Inc. · NASDAQ:PYXS

Orbimed Advisors LLC reported a 3.60% stake in Pyxis Oncology, Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Nov 16, 2026

Orbimed Advisors LLC reported a 3.60% stake in Pyxis Oncology, Inc., 4,348,197 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).

Stake
3.60%
Shares
4,348,197
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC3.40%4,013,720
OrbiMed Capital LLC3.60%4,348,197

Source

Download original · View original at SEC

Related